Literature DB >> 2786775

Systemic delayed-type hypersensitivity to cholera toxin and a detoxified derivative.

R A Kay1, A Ferguson.   

Abstract

The delayed-type hypersensitivity (DTH) response to cholera toxin (CT) and an immunopurified formalinized toxoid (TD) was studied in adult BALB/c mice. Intradermal injection of CT in non-immune animals produced substantial footpad oedema which interfered with the measurement of specific DTH but TD proved satisfactory as a challenge antigen. DTH to CT was induced by doses ranging from 0.1 to 10 micrograms, in complete Freund's adjuvant (CFA). The optimal reaction was primed for by 1 microgram CT. Doses of TD with an equivalent B subunit content were equally capable of inducing DTH as the holotoxin. The time-course of the footpad swelling revealed that the DTH response was biphasic. Histological examination showed that the initial swelling was due to tissue oedema and the subsequent increase in footpad thickness was associated with a mononuclear cell infiltrate at the site of antigen challenge. Adoptive transfer experiments were used to demonstrate that the DTH was antigen-specific and could be passively transferred by immune effector T cells. This is the first study to demonstrate an effector T cell response to CT. A role for T cell reactions in the intestinal mucosa must now be examined as a potential contributory mechanism in the prevention of choleraic diarrhoea.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2786775      PMCID: PMC1541723     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  26 in total

1.  Adjuvant effect of cholera enterotoxin on the immune response of the mouse to sheep red blood cells.

Authors:  R S Northrup; A S Fauci
Journal:  J Infect Dis       Date:  1972-06       Impact factor: 5.226

2.  Clones of helper T cells mediate antigen-specific, H-2-restricted DTH.

Authors:  A T Bianchi; H Hooijkaas; R Benner; R Tees; A A Nordin; M H Schreier
Journal:  Nature       Date:  1981-03-05       Impact factor: 49.962

3.  The role of T cells in IgG production; thymus-dependent antigens induce B cell memory in the absence of T cells.

Authors:  J W Schrader
Journal:  J Immunol       Date:  1975-06       Impact factor: 5.422

4.  [Quantitative evaluation of Vibrio cholerae colonization and lymphocyte count in small intestine villi of rabbits immunized with vibrio and cholera toxin].

Authors:  V E Efremov; Iu E Polotskiĭ; A Iu Samostrel'skiĭ; N R Vasser; V G Selivestrova
Journal:  Zh Mikrobiol Epidemiol Immunobiol       Date:  1982-02

5.  Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens.

Authors:  N Lycke; J Holmgren
Journal:  Immunology       Date:  1986-10       Impact factor: 7.397

6.  An early component of delayed-type hypersensitivity mediated by T cells and mast cells.

Authors:  H van Loveren; R Meade; P W Askenase
Journal:  J Exp Med       Date:  1983-05-01       Impact factor: 14.307

7.  Effects of cholera toxin on the lymphoid system II. Selective augmentation of delayed footpad reaction in mice.

Authors:  S Tsuru; Y Zinnaka; K Nomoto; K Takeya
Journal:  J Clin Lab Immunol       Date:  1981-09

8.  Antitoxic immunity in experimental cholera: observations with purified antigens and the rat foot edema model.

Authors:  R A Finkelstein; R C Hollingsworth
Journal:  Infect Immun       Date:  1970-05       Impact factor: 3.441

9.  Induction of a mucosal antitoxin response and its role in immunity to experimental canine cholera.

Authors:  N F Pierce; W C Cray; B K Sircar
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

10.  Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen.

Authors:  C O Elson; W Ealding
Journal:  J Immunol       Date:  1984-12       Impact factor: 5.422

View more
  1 in total

1.  Protection of rat intestine against cholera toxin challenge by monoclonal anti-idiotypic antibody immunization via enteral and parenteral routes.

Authors:  G P Lucas; C L Cambiaso; J P Vaerman
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.